BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21700955)

  • 1. DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells.
    Chimonidou M; Strati A; Tzitzira A; Sotiropoulou G; Malamos N; Georgoulias V; Lianidou ES
    Clin Chem; 2011 Aug; 57(8):1169-77. PubMed ID: 21700955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX17 promoter methylation in circulating tumor cells and matched cell-free DNA isolated from plasma of patients with breast cancer.
    Chimonidou M; Strati A; Malamos N; Georgoulias V; Lianidou ES
    Clin Chem; 2013 Jan; 59(1):270-9. PubMed ID: 23136251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CST6 promoter methylation in circulating cell-free DNA of breast cancer patients.
    Chimonidou M; Tzitzira A; Strati A; Sotiropoulou G; Sfikas C; Malamos N; Georgoulias V; Lianidou E
    Clin Biochem; 2013 Feb; 46(3):235-40. PubMed ID: 23006792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells.
    Chimonidou M; Kallergi G; Georgoulias V; Welch DR; Lianidou ES
    Mol Cancer Res; 2013 Oct; 11(10):1248-57. PubMed ID: 23744981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a multiplex methylation specific PCR-coupled liquid bead array for liquid biopsy analysis.
    Parisi C; Mastoraki S; Markou A; Strati A; Chimonidou M; Georgoulias V; Lianidou ES
    Clin Chim Acta; 2016 Oct; 461():156-64. PubMed ID: 27510924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions.
    Rivenbark AG; Livasy CA; Boyd CE; Keppler D; Coleman WB
    Exp Mol Pathol; 2007 Oct; 83(2):188-97. PubMed ID: 17540367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer.
    Chimonidou M; Strati A; Malamos N; Kouneli S; Georgoulias V; Lianidou E
    Oncotarget; 2017 Sep; 8(42):72054-72068. PubMed ID: 29069768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
    Kioulafa M; Balkouranidou I; Sotiropoulou G; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
    Int J Cancer; 2009 Dec; 125(12):2887-92. PubMed ID: 19551853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA methylation modification of BRMS1 in triple-negative breast cancer and its correlation with tumor metastasis].
    Xia J; Lü ZD; Zhou PH; Cui SC; Kong B; Liu D; Long SS; Zhang XH; Zhao JJ
    Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(44):3483-3487. PubMed ID: 29275584
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
    Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.
    Dimitrakopoulos L; Vorkas PA; Georgoulias V; Lianidou ES
    BMC Cancer; 2012 Oct; 12():486. PubMed ID: 23088560
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Politaki E; Voutsina A; Psyrri A; Georgoulias V; Lianidou E
    Clin Cancer Res; 2018 Mar; 24(6):1500-1510. PubMed ID: 29284708
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer.
    Balgkouranidou I; Chimonidou M; Milaki G; Tsarouxa EG; Kakolyris S; Welch DR; Georgoulias V; Lianidou ES
    Br J Cancer; 2014 Apr; 110(8):2054-62. PubMed ID: 24642624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Preanalytical Conditions and Implementation of Quality Control Steps for Reliable Gene Expression and DNA Methylation Analyses in Liquid Biopsies.
    Zavridou M; Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Lianidou E
    Clin Chem; 2018 Oct; 64(10):1522-1533. PubMed ID: 30018056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer.
    Metge BJ; Frost AR; King JA; Dyess DL; Welch DR; Samant RS; Shevde LA
    Clin Exp Metastasis; 2008; 25(7):753-63. PubMed ID: 18566899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay.
    Markou A; Strati A; Malamos N; Georgoulias V; Lianidou ES
    Clin Chem; 2011 Mar; 57(3):421-30. PubMed ID: 21245367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox17 promoter methylation in plasma DNA is associated with poor survival and can be used as a prognostic factor in breast cancer.
    Fu D; Ren C; Tan H; Wei J; Zhu Y; He C; Shao W; Zhang J
    Medicine (Baltimore); 2015 Mar; 94(11):e637. PubMed ID: 25789956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
    Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
    Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.